Ironwood Pharmaceuticals
edit

Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. It engages in developing a pipeline of clinical candidates in the areas of gastrointestinal diseases, cardiovascular diseases, pain, and inflammation. The company’s operationally independent subsidiary, Microbia Inc., engages in developing and commercializing bioprocesses for use in pharmaceuticals, foods, and specialty and industrial chemicals. Ironwood Pharmaceuticals, Inc. was formerly known as Microbia, Inc. The company was founded in 1998 and is headquartered in Cambridge, Massachusetts.

Recent Milestones
edit

Ironwood Pharmaceuticals — collaborating with Protagonist Therapeutics Inc. of Redwood City, Calif., to discover novel peptides for potential development by Ironwood (1/19/11)

Posted 1/20/11 at 3:55am via masshightech.com
Ironwood Pharmaceuticals — A treatment for irritable bowel syndrome developed by Cambridge-based Ironwood Pharmaceuticals Inc. (Nasdaq: IRWD) and partner Forest Laboratories Inc. (NYSE: FRX), of New York, has achieved positive results in a second Phase 3 clinical trial, meeting bot (11/2/10)

Posted 11/3/10 at 3:18am via masshightech.com
Ironwood Pharmaceuticals — Microbia Inc., the Lexington subsidiary of Cambridge-based Ironwood Pharmaceuticals Inc., has been acquired by Dutch life sciences firm Royal DSM N.V (9/22/10)

Posted 9/23/10 at 3:28am via masshightech.com
Ironwood Pharmaceuticals — Microbia Inc., a subsidiary of Ironwood Pharmaceuticals, has been acquired by Royal DSM N.V. (9/22/10)

Posted 9/22/10 at 10:05am via masshightech.com
Went public with stock symbol NASDAQ:IRWD. (2/3/10)

Posted 7/2/10 at 8:56am
Ironwood Pharmaceuticals received $50M in Series D funding. (10/1/08)

Posted 2/1/10 at 3:37pm via ironwoodpharma.com
Ironwood Pharmaceuticals added Joseph C. Cook as Co-Founder and Chairman .

Posted 11/23/09 at 7:08pm
Ironwood Pharmaceuticals added Peter M. Hecht as Co-Founder.

Posted 11/23/09 at 7:08pm
Ironwood Pharmaceuticals added Brian M. Cali as Co-Founder and Vice President of Program Management.

Posted 11/23/09 at 7:08pm
Ironwood Pharmaceuticals added Gina Bornino Miller as Co-Founder and Director.

Posted 11/23/09 at 7:08pm